Peripheral blood contains non-cellular vesicles surrounded by phospholipid bilayers. These are collectively referred to as extracellular vesicles (EVs). Disease-associated EVs, such as tumor-derived EVs, are attracting attention as new biomarkers. We aimed to construct a method of quantifying EVs, and here we introduce the strategy developed in this research. The method consists of the simple steps of (1) purifi cation of the target EVs and (2) phospholipid bilayer staining. As a disease model, EVs were prepared from cultured cell supernatant, and an immunomagnetic positive separation technique was used for EV purifi cation. Specifi cally, superparamagnetic submicron particles were conjugated with an antibody against CD326 (EpCAM), which is expressed at high levels in many epithelial cancers, and an antibody against CD142 (tissue factor), which can cause thromboembolism. By selecting an appropriate lipid stain, it was possible to detect the target EVs with high sensitivity, and their positivity was easily judged: the strength of the signal from the stained lipid was correlated with the surface area of the EVs (independently of the amount of surface antigen).
Therefore, any ambiguity due to variation in EV size and the amount of antigen per particle was resolved. Here, we give examples of quantitative measurements using a conventional fl ow cytometry analyzer. We discuss the applicability of this strategy of EV purifi cation and phospholipid staining to an antibody array and imaging analysis that allows the simultaneous detection of multiple EVs.
抄録全体を表示